This is a preprint.
Measuring Stigma Associated with Hepatitis B Virus Infection in Sierra Leone: Validation of an Abridged Berger HIV Stigma Scale
- PMID: 36824916
- PMCID: PMC9949200
- DOI: 10.1101/2023.02.17.23286086
Measuring Stigma Associated with Hepatitis B Virus Infection in Sierra Leone: Validation of an Abridged Berger HIV Stigma Scale
Update in
-
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale.J Viral Hepat. 2023 Jul;30(7):621-629. doi: 10.1111/jvh.13838. Epub 2023 Apr 21. J Viral Hepat. 2023. PMID: 37084170 Free PMC article.
Abstract
Stigma associated with hepatitis B virus (HBV) is common in endemic countries; however; instruments are lacking to accurately measure HBV-related stigma. We therefore aimed to develop and validate a concise instrument for measuring perceived HBV-related stigma in Sierra Leone. We enrolled 220 people living with HBV (PWHB) aged ≥ 18 years from August to November 2022. The initial Likert-scale instrument entailed 12 items adapted from Berger's HIV Stigma Scale. We included 4 additional items adapted from the USAID indicators for enacted stigma. The proposed scale's psychometric properties were assessed. After item reduction, the final HBV Stigma Scale consisted of 10 items and had good internal consistency (overall Cronbach's α = 0.74), discriminant and construct validity. Exploratory factor analysis produced a 3-dimensional structure accounting for 59.3% of variance: personalized stigma driven by public attitudes (6 items), negative self-image (2 items), and disclosure concerns (2 items). Overall, 72.8% of respondents reported perceived HBV stigma (mean score 29.11 ± 4.14) and a similar a proportion (73.6%) reported at least one instance of enacted stigma. In assessing criterion-related validity, perceived HBV-related stigma correlated strongly with enacted stigma (r = 0.556) and inversely with having family/friends with HBV (r = -0.059). The 10-item HBV Stigma Scale demonstrated good internal consistency and validity and is suitable for screening for HBV-related stigma in Sierra Leone. The psychometric properties of the scale can be optimized with item additions/modifications and confirmatory factor analysis. The scale may help in combating stigma as a barrier to achieving HBV global elimination goals.
Conflict of interest statement
CONFLICTS OF INTEREST
The authors report no relevant financial disclosures or conflicts of interests.
Figures
References
-
- World Health Organization. Hepatitis B. Geneva, Switzerland, 2022. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 10 February 2023.
-
- World Health Organization. Final global health sector strategies on respectively, HIV, viral hepatitis and sexually transmitted infections, 2022-2030. https://www.who.int/publications/i/item/9789240053779 Accessed 10 February 2023.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources